Sign in

CIK 0001517022 · Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
208756903
Phone
617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 4 Option exercise CEO and President acquired 350,000 shares (option exercise)
  2. 4 Planned sale SVP, CFO, CBO & Treasurer sold 56,019 shares at $1.11 ($62,181)
  3. 4 Grant or award Director acquired 35,700 shares (grant or award)
  4. 4 Grant or award Director acquired 35,700 shares (grant or award)
  5. 4 Grant or award Director acquired 35,700 shares (grant or award)
  6. 4 Grant or award Director acquired 35,700 shares (grant or award)
  7. 4 Grant or award Director acquired 35,700 shares (grant or award)
  8. 4 Grant or award Director acquired 35,700 shares (grant or award)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market buy CEO and President bought 69,270 shares at $1.25 ($86,588)
  12. 4 Planned sale SVP, Chief Accounting Officer sold 49,524 shares at $1.39 ($68,838)
  13. 4 Planned sale Chief Commercial Officer sold 84,829 shares at $1.39 ($117,912)
  14. 4 Planned sale SVP, Chief Medical Officer sold 67,658 shares at $1.39 ($94,045)
  15. 4 Planned sale SVP, Chief Legal Officer sold 69,772 shares at $1.39 ($96,983)
  16. 4 Planned sale SVP, CFO, CBO & Treasurer sold 34,951 shares at $1.39 ($48,582)
  17. 4 Planned sale CEO and President sold 341,305 shares at $1.39 ($474,414)
  18. 4 Grant or award Chief Commercial Officer acquired 204,000 shares (grant or award)
  19. 4 Grant or award SVP, Chief Medical Officer acquired 204,000 shares (grant or award)
  20. 4 Grant or award SVP, Chief Legal Officer acquired 190,000 shares (grant or award)

Page 1 of 19 · 378 filings